GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
In June, GSK released results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial of Blenrep in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, ...
Zacks.com on MSN5h
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...
12 High Growth Large Cap Stocks to Buy Now
In this article, we will discuss the 12 High Growth Large Cap Stocks to Buy Now. BlackRock highlighted that its portfolio ...
Business Insider9h
Vaccine makers fall after Trump nominates RFK to head HHS
Shares of vaccine makers, including Moderna (MRNA), BioNTech (BNTX), Pfizer (PFE), Novavax (NVAX), Vaxcyte (PCVX) and GSK (GSK) moved lower at the end of the trading day following reports that ...
Do You Believe in Humana Inc. (HUM)’s Long-Term Strength?
Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2024 investor letter. A ...
Stocks on Sale: CVS Health, Moderna, and Albemarle
When CVS Health (CVS) jumped, trading above $60, the rally did not last. Markets initially responded well to CVS’s Q3 results ...
The Globe and Mail20h
Stocks Sharply Higher as Trump Wins Presidential Election
Coupang (CPNG) fell -10% after reporting Q3 retail net sales of $6.14 billion ... Insulet Corp (PODD), Kenvue Inc (KVUE), Mettler-Toledo International Inc (MTD), Moderna Inc (MRNA), Molson Coors ...